13F HOLDINGS REPORT
Foresite Capital Management V, LLC
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0001104659-23-019781
Total Value
$128.8M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Hims & Hers Health, Inc. | HIMS | 4,041,383 | $25.9M | 20.12% |
| 2 | Compass Therapeutics, Inc. | CMPX | 4,400,000 | $22.1M | 17.19% |
| 3 | Aclaris Therapeutics, Inc. | ACRS | 1,258,243 | $19.8M | 15.39% |
| 4 | Theseus Pharmaceuticals, Inc. | 88369M101 | 3,585,346 | $17.9M | 13.87% |
| 5 | Pardes Biosciences Inc | 69945Q105 | 10,037,935 | $17.0M | 13.18% |
| 6 | Somalogic, Inc. | 83444K105 | 3,516,472 | $8.8M | 6.86% |
| 7 | Kinnate Biopharma Inc. | 49705R105 | 875,001 | $5.3M | 4.15% |
| 8 | Adicet Bio, Inc. | ACET | 558,636 | $5.0M | 3.88% |
| 9 | Disc Medicine, Inc. | IRON | 243,513 | $4.8M | 3.76% |
| 10 | Quantum-Si Incorporated | QSIAW | 924,379 | $1.7M | 1.31% |
| 11 | Pharvaris N.V. | PHVS | 34,142 | $384,098 | 0.30% |